Log In
CQMS
Make a Donation
Log In
Donate
TROG 2026 ASM: Early Bird Registration now open
Our Km's for Cancer Research challenge is underway - join now
$1.9 million grant sees TROG bring international trial to Australia
Apply now for Attendance Grants for our 2026 ASM

TROG 04.02 – Cervical – FIGO Stage & Tumour Volume

Completed
Gynaecological

Prospective Study to Determine the Relationships Between Survival and FIGO Stage, Tumour Volume and Corpus Invasion in Cervical Cancer.

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Registration Link

Prev Post

AG0307OS/TROG08.07 – DECO

Next Post

NCIC CTG CE.6/TROG 08.02 – GBM in Elderly Patients

Related Post

Prof Wee Loon Ong
24 September, 2025

Prostate Cancer Month: Focus on the TROG Genitourinary Working Party

To mark Prostate Cancer Month in September, we asked

24 September, 2025

TROG members and staff celebrate World Radiotherapy Awareness Day

LATEST NEWS: 24 September 2025 TROG Cancer Research staff